Neue chirale Phosphanliganden - Synthese und Anwendungen in der asymmetrischen Katalyse

Neue chirale Phosphanliganden - Synthese und Anwendungen in der asymmetrischen Katalys

Cerebrospinal Fluid Tau Protein Levels and F-18-Fluorodeoxyglucose Positron Emission Tomography in the Differential Diagnosis of Alzheimer's Disease

Aims: In this study, we aimed to compare cerebrospinal fluid (CSF) levels of total tau (t-tau), phosphorylated tau (p-tau(181)) and positron emission tomography with F-18-fluorodeoxyglucose (FDG-PET) in the differential diagnosis of Alzheimer's disease (AD) under clinical conditions. Method: In a cross-sectional, blinded, single-center study, we examined a sample of 75 unselected memory clinic patients with clinical diagnoses of dementia of Alzheimer type (DAT; n = 24), amnestic mild cognitive impairment (MCI; n = 16), other dementias (n = 13) and nondemented controls (n = 22). Discriminative accuracy, sensitivity and specificity were calculated and compared using ROC analyses. Results: p-tau(181) and FDG-PET were comparable in separating DAT from controls (sensitivity: 67 vs. 79%; specificity: 91% for both) and patients with other dementias (sensitivity: 71 vs. 79%; specificity: 100% for both). The sensitivity of p-tau 181 in differentiating MCI patients from controls was significantly (p < 0.05) superior to that of FDG-PET (75 vs. 44%) at a comparably high specificity (82 vs. 91%); t-tau measures were less accurate in all analyses. Conclusions: FDG-PET and CSF p-tau(181) levels are able to discriminate DAT in heterogeneous and unselected samples with a high accuracy. CSF p-tau(181) might be somewhat superior for a sensitive detection of patients with MCI. Copyright (C) 2010 S. Karger AG, Base

Strategies for Accelerating the Development of Catalytic Enantioselective Reactions

The development of enantioselective catalytic processes for the manufacture of chiral intermediates is a very complex endeavor and can be very time consuming and expensive. In this contribution the major issues which might lead to long development times will be discussed and strategies to deal with these problems are described. The general part is illustrated with the approach Solvias has chosen for assisting and supporting the development of enantioselective homogeneous hydrogenation processes, at the moment the most important industrial application of asymmetric catalysis. Special emphasis is given to the application of high-throughput screening (HTS) using a Symyx HiP system and the description of the Solvias portfolio of chiral ligands which makes a broad variety of diphosphine ligands available for all phases of process development from the first screening experiments to the large-scale manufacturing phase. Four case histories serve to illustrate the generic description of the development process

The Wooster Voice (Wooster, OH), 1946-10-04

The football team has sustained an abundance of injuries over the past week. Both staff and students are having difficulties with not have enough housing spaces, nor enough classrooms. The first year senate chair will be Don Shawver. Students have voted in favor for having a homecoming queen by 757 for and 128 against. On the thirteenth of October, the Inter-Club Council will be hosting a tea for any freshman girl who is interested in joining a section. A feature is written about how a Latin American student views the College of Wooster. Emory Anderson writes about how squirrels are slowly dominating the world.https://openworks.wooster.edu/voice1941-1950/1128/thumbnail.jp

Gadolinium-based Contrast Agents for Cardiac MRI:Use of Linear and Macrocyclic Agents with Associated Safety Profile from 154 779 European Patients

Purpose: To assess current use and acute safety profiles of gadolinium-based contrast agents (GBCAs) in cardiac MRI given recent suspensions of GBCA approval. Materials and Methods: Patients were retrospectively included from the multinational multicenter European Society of Cardiovascular Radiology (ESCR) MR/CT Registry collected between January 2013 and October 2019. GBCA-associated acute adverse events (AAEs) were classified as mild (self-limiting), moderate (pronounced AAE requiring medical management), and severe (life threatening). Multivariable generalized linear mixed-effect models were used to assess AAE likelihood. Results: A total of 154 779 patients (average age, 53 years ± 19 [standard deviation]; 99 106 men) who underwent cardiac MRI were included, the majority of whom underwent administration of GBCAs (94.2% [n = 145 855]). While linear GBCAs were used in 15.2% of examinations through 2011, their use decreased to less than 1% in 2018 and 2019. Overall, 0.36% (n = 556) of AAEs were documented (mild, 0.12% [n = 178]; moderate, 0.21% [n = 331]; severe, 0.03% [n = 47]). For nonenhanced cardiac MRI, examination-related events were reported in 2.59% (231 of 8924) of cases, the majority of which were anxiety (0.98% [n = 87]) and dyspnea (0.93% [n = 83]). AAE rates varied significantly by pharmacologic stressor, GBCA molecular structure (macrocyclic vs linear GBCA: multivariable odds ratio, 0.634; 95% confidence interval: 0.452, 0.888; P = .008), GBCA subtype, and imaging indication. Conclusion: Gadolinium-based contrast agent administration changed according to recent regulatory decisions, with use of macrocyclic agents almost exclusively in 2018 and 2019; these agents also demonstrated a favorable acute safety profile.Supplemental material is available for this article.© RSNA, 2020

Microgravity facilities for cold atom experiments

Microgravity platforms enable cold atom research beyond experiments in typical laboratories by removing restrictions due to the gravitational acceleration or compensation techniques. While research in space allows for undisturbed experimentation, technological readiness, availability and accessibility present challenges for experimental operation. In this work we focus on the main capabilities and unique features of ground-based microgravity facilities for cold atom research. A selection of current and future scientific opportunities and their high demands on the microgravity environment are presented, and some relevant ground-based facilities are discussed and compared. Specifically, we point out the applicable free fall times, repetition rates, stability and payload capabilities, as well as programmatic and operational aspects of these facilities. These are contrasted with the requirements of various cold atom experiments. Besides being an accelerator for technology development, ground-based microgravity facilities allow fundamental and applied research with the additional benefit of enabling hands-on access to the experiment for modifications and adjustments

Acute adverse events in cardiac MR imaging with gadolinium-based contrast agents:results from the European Society of Cardiovascular Radiology (ESCR) MRCT Registry in 72,839 patients

International audienc